Author: admin

  • Bay FC Trade for Canadian International Defender Sydney Collins

    Bay FC Trade for Canadian International Defender Sydney Collins

    Talented defender comes to Bay FC through trade with North Carolina Courage

    SAN JOSE, Calif. (August 22, 2025) – Bay FC announced today the club has acquired defender Sydney Collins ahead of this weekend’s match against the Washington Spirit in a trade with the North Carolina Courage. The Canadian joins Bay FC immediately after the club acquired her for the remainder of the 2025 season in exchange for $60,000 in 2025 intra-league transfer funds from the North Carolina Courage. Collins will be available for selection for Bay FC this weekend.

    “We are delighted to welcome Sydney Collins to Bay FC,” said head coach Albertin Montoya. “Sydney is a highly talented defender whose skill set and composure make her an excellent fit within the dynamics of our roster. Her international experience with Canada has further shaped her into a confident and reliable player, and her presence will provide immediate impact while also helping to strengthen and solidify our backline for the future.”

    “I am thrilled to be joining Bay FC and to return to the Bay Area, which is home for me,” said Collins, “I’m excited for the opportunity to play in front of such incredible fans, and I am thrilled to be part of the strong culture the club is building. I look forward to working with my teammates, the staff, and everyone at the club as we continue to build for the future.”

    Collins began her professional career with North Carolina in 2023, being selected eighth overall in the 2023 NWSL draft. Her rookie season, she appeared in four matches for the club, tallying 194 minutes. She spent the 2024 season and start of 2025 on the season-ending injury list, being activated last month and returning to the pitch as a substitute and logging 29 minutes in a 4-0 friendly victory vs. Mexican side Chivas July 26.

    A Canadian international, Collins helped Les Rouges qualify for the 2024 Olympics and was set to join the squad in Paris before suffering an injury in preparation for the tournament. Collins spent her college career locally at Cal, playing four seasons with the Golden Bears and earning Third Team All-Pac-12 honors in 2021 and Second Team All-Pac-12 honors in 2022.

    Bay FC hosts the Washington Spirit for ‘The Show’ this weekend at San Francisco’s Oracle Park, home of the San Francisco Giants. The club is set to break the all-time single-match attendance record for all U.S. women’s professional league sports at the match and fans are encouraged to buy tickets as soon as possible to ensure their seat at this historic match.

    Kickoff is set for 1 p.m. PT before a national audience on CBS, and fans are encouraged to arrive early to take in special performances inside and outside the ballpark ahead of kickoff and grab a Bay FC x Oracle Park flag giveaway. Limited tickets are still available by visiting BayFC.com/OraclePark.

    About Bay Football Club
    Bay Football Club (Bay FC) is the professional soccer franchise representing the Bay Area and the 14th team to join the National Women’s Soccer League (NWSL). Bay FC was established in April 2023 and co-founded by USWNT legends Brandi Chastain, Leslie Osborne, Danielle Slaton, and Aly Wagner in partnership with global investment firm Sixth Street and an investor group of leading tech, business and sports executives. Sixth Street’s investment is the largest institutional investment to date in a women’s professional sports franchise. Bay FC is changing the face of women’s soccer as we know it. The Club began play in the 2024 season. Tickets are now on sale for Bay FC at BayFC.com and fans can follow Bay FC’s social channels (@wearebayfc) for the latest news, merchandise, and events.


    Continue Reading

  • DPM reviews availability, prices of essential commodities – RADIO PAKISTAN

    1. DPM reviews availability, prices of essential commodities  RADIO PAKISTAN
    2. DPM highlights Govt’s commitment to ensuring price stability, adequate supplies of essential goods  Associated Press of Pakistan
    3. Dar reviews prices, supplies of essential goods in market  24 News HD
    4. DPM underscores need to enhance petroleum exploration, increase productivity for affordable energy  Associated Press of Pakistan

    Continue Reading

  • The squad’s first impressions of Mbeumo

    The squad’s first impressions of Mbeumo

    The Cameroon international has proved a big hit with supporters since signing on the dotted line from Brentford last month, and it may not come as a surprise to learn that our no.19 has been a popular addition to the Old Trafford dressing room too.

    In the second episode of our ‘First Impressions’ series, nine Reds rate Bryan, all of them very highly…

    Matthijs de Ligt: “He’s a really nice guy, really humble. It’s really nice speaking to him. I really like him as a person. His finishing, his speed, his strength: he’s a really good player and obviously he already showed it in the Premier League, so I think he can be a really good player for us and he can help us a lot. I think he’s not even fit yet, he knows he has to work hard, because obviously he’s been short of pre-season because he didn’t train at Brentford. I think he’s already shown so much quality but when he becomes even more fit, you’ll see the real potential coming out. I can’t wait to see that, because it will help us as a team massively.”

    Continue Reading

  • 1,800 Global Leaders Converge in Paris for the Most Powerful Week in Space

    1,800 Global Leaders Converge in Paris for the Most Powerful Week in Space

    Paris, August 20, 2025 – In less than 30 days, Paris becomes the center of the space economy. From September 15 to 19, 2025, more than 1,800 decision-makers, 250+ top-tier speakers, and 600+ organizations from 60+ countries will unite at World Space Business Week (WSBW), the Space Defense and Security Summit (SDSS), and the newly launched Space Innovation Summit (SPIN).

    Together, these three flagship events form the world’s most influential gathering of defense leaders, government officials, business executives, innovators, and investors — where strategies are set, deals are signed, and the future of space is defined.

    Three Events. One Global Stage.

    World Space Business Week (WSBW) | September 15–19, 2025 – Hôtel du Collectionneur
    1,400 decision-makers | 200+ top-tier speakers | 600+ organizations | 60+ countries
    The premier global space business event spotlighting market trends, investment flows, satellite communications, Earth observation, mobility, and space infrastructure.

    Space Defense and Security Summit (SDSS) | September 16–17, 2025 – Les Salons Hoche
    300+ decision-makers | 60+ global speakers | 50+ institutions | 35+ countries
    A strategic platform for governments, militaries and industry leaders to address the evolving challenges of space defense, resilience, and security.

    Space Innovation Summit (SPIN) | September 17, 2025 – Hôtel du Collectionneur
    200+ decision-makers | 80+ organizations | 25+ speakers
    Novaspace’s newest summit, dedicated to breakthrough technologies, start-up showcases, dual-use innovations, and entrepreneurial visions transforming the space sector.

    The strategic proximity of the three events provides an unparalleled environment for connecting with potential investors, innovators, clients, and partners — driving cross-sector collaboration and real deal-making opportunities.

    World-class Lineup of Global Space Leaders

    Notable confirmed speakers include European Commissioner Andrius Kubilius, General Brian W. Gibson (United States Space Command), General Vincent Chusseau (French Space Command), General Michael Traut (German Space Command), Jeong Gyuheon (Defense Acquisition Program Administration – DAPA), Josef Aschbacher (ESA), Gwynne Shotwell (SpaceX), Adel Al-Saleh (SES), Max Haot (Vast), Jean-François Fallacher (Eutelsat Group), and Ricky Freeman (Amazon Kuiper Government Services) — among many other government representatives, high-ranking officers, C-level executives, investors, and innovators shaping the next era of the global space domain.

    A Pivotal Moment for the Space Domain

    “With these three summits taking place simultaneously, Paris becomes the decision-making hub for the global space domain,” said Pacôme Révillon, CEO of Novaspace. “We are proud to host the conversations, partnerships, and deals that will shape the industry for years to come.”

    ***

    About Novaspace
    Novaspace is a global leader in space consulting and market intelligence, formed through the merger of Euroconsult and SpaceTec Partners. This strategic move combines the distinctive strengths of both entities to significantly amplify our international presence and service capabilities. With over 40-year legacy of expertise in guiding public and private entities in strategic decision-making, Novaspace offers end-to-end consulting services, from project strategy definition to implementation, providing data-led perspectives on critical issues. Novaspace presents an expanded portfolio of services, featuring combined expertise in management and technology consulting, top-tier executive summits, and market intelligence. Trusted by 1,200 clients in over 60 countries, with offices strategically located in Brussels, London, Montreal, Munich, Paris, Singapore, Sydney, Tokyo, Toulouse, and Washington D.C.

    Media Enquiries: Olivia Garnier | Communications Lead | olivia.garnier@nova.space

    Continue Reading

  • UMass Chan scientists explain how transcription factors compete with DNA repair operations, increasing errors that lead to mutations

    UMass Chan scientists explain how transcription factors compete with DNA repair operations, increasing errors that lead to mutations

    Raluca Gordan, PhD
    Photo: Bryan Goodchild

    Scientists at UMass Chan Medical School have explained how proteins that regulate gene function called transcription factors (TF) can increase genetic mutations by competing with DNA repair operations during genome replication. Published in Cell, these findings show that this natural rivalry between TFs and DNA repair can explain, in part, why TF binding sites show an increased mutation rate compared to the rest of the genome, especially in cancer cells. 

    Mutation rates vary greatly across the human genome, with some areas being far more prone to errors. Studies have shown that mutations at regulatory sites bound by TFs happen at a higher rate compared to the rest of the genome, but the reasons for this are not well understood.  

    “Cancer cells accumulate a lot of mutations. Some are more important than others,” said Raluca Gordan, PhD, professor of genomics & computational biology. “Our results show that many mutations prevalent in TF binding sites are less likely to be selected for cancer cell survival, and instead are the result of a natural competition between TFs and DNA repair, which means that such mutations should not be prioritized for screening and in-depth studies by scientists.” 

    The DNA mismatch repair mechanism is a crucial component in maintaining genetic fidelity from a parent cell to a daughter cell. Mismatch repair (MMR) proteins, like MutSα, scan the DNA of a daughter cell as it is being copied—a process called DNA replication—before cell division starts to ensure that it matches the parent cell. If the MMR protein finds a mistake, it signals the cell to cut out the DNA region containing the incorrect nucleotide and replace it with a correct sequence. This helps maintain genetic stability from one cell generation to the next. 

    Studying single nucleotide errors, however, is challenging for scientists. These errors are very rare, occurring at most once in every 1 million cell divisions.  

    “You can’t do a study based on one cell,” said Wei Zhu, PhD, a former student in Dr. Gordan’s lab at Duke University and now a postdoctoral fellow at Harvard Medical School. “You’d have to sequence millions and millions and millions of cells to assemble enough mutations to study this phenomenon.”

    Wei Zhu, PhD
    Wei Zhu, PhD
    Photo
    : HuthPhoto, Durham, NC

    Additionally, modern genome sequencing technologies aren’t accurate enough for this kind of work. Even the best technologies have an error rate in the thousands, which is far higher than the 1 in a 1 million rate of replication errors Gordan and colleagues were hoping to study. For small genomic areas, such as TF sites that span only 10 to 20 base pairs, quantifying mutations that result from replication errors is practically impossible with current sequencing technologies.  

    To overcome these challenges, Gordan and colleagues developed a mutagenic system using yeast genetics. This system allowed scientists to easily isolate and select cells for very specific mutations—down to the nucleotide—in TF binding sites. This technique allowed them to produce the quantity of nucleotide-specific mutated cells for testing.  

    They then tested these mutations to determine how well the TF protein, versus the MMR protein MutSα, bound to the DNA mismatch errors that gave rise to the mutations. What they found was that these mismatches were preferentially bound by the TF instead of MutSα. As a result, these mismatch replication errors were less likely to be recognized and fixed by MutSα and were instead being passed down to daughter cells. In following cell generations, these unrepaired mismatches then show up as mutations.  

    “From an evolutionary perspective it is easier for a cell to evolve a TF binding site than a gene,” said Dr. Zhu. “For this reason, you can understand how the TF-MMR competition that we discovered can, over time, lead to beneficial mutations that are selected and maintained by the organism. In cancer cells, however, this natural TF-MMR competition process can be problematic for two reasons. First, having more mutations in TF binding sites gives the cancer cells more mutations to select from for increased survival. Second, even when the mutations resulting from TF-MMR competition aren’t doing anything and are just along for the ride, they can obscure cancer-promoting mutations that now become harder to detect.” 

    Gordan and colleagues plan to model the formation of mutations in cancer cells to identify specific mutations that are more common in cancer but cannot be explained by this newly discovered TF-MM competition mechanism.


    Continue Reading

  • Development Program for KB707 Will Prioritize Inhaled Formulation for NSCLC

    Development Program for KB707 Will Prioritize Inhaled Formulation for NSCLC

    Image Credit:
    © Ashling Wahner &
    MJH Life Sciences Using AI

    The development program for the immunotherapy KB707 will prioritize an inhaled formulation of the agent for the treatment of patients with non–small cell lung cancer (NSCLC), according to an announcement from Krystal Biotech.1

    As such, the company announced it was also pausing enrollment of the phase 1/2 OPAL-1 trial (NCT05970497) evaluating intratumoral KB707 in patients with locally advanced or metastatic solid tumor malignancies.

    The company was also granted an end of phase 2 meeting with the FDA in October 2025 to further discuss developmental pathways for inhaled KB707.

    “The acceleration of our work on inhaled KB707 is a reflection of both the clear and acute unmet need that exists for new treatments of NSCLC and the promising efficacy profile we have observed to date with inhaled KB707,” Suma Krishnan, president of Research and Development of Krystal Biotech, stated in a news release. “We look forward to meeting with the FDA and bringing another urgently needed therapeutic option to patients.”

    Data from the phase 1/2 KYANITE-1 trial (NCT06228326) presented at the 2025 ASCO Annual Meeting showed that efficacy-evaluable patients with NSCLC treated with inhaled KB707 (n = 11) achieved an overall response rate (ORR) of 27% as of the abstract data cutoff; patients experienced partial response (PR; n = 3), stable disease (n = 5), or progressive disease (n = 3).2 With extended follow-up, the ORR was 36%, with 4 patients achieving a PR.

    Regarding safety, any-grade treatment-related adverse effects (TRAEs) were reported in 66.7% of patients, although no grade 4 or 5 TRAEs occurred. The most common any-grade TRAEs comprised chills (25.6%), cytokine release syndrome (CRS; 23.1%), fatigue (20.5%), flu-like illness (15.4%), dyspnea (15.4%), vomiting (12.8%), and pyrexia (10.3%). Notably, the rate of grade 3 CRS was 2.6%.

    KB707 Background and KYANITE-1 Overview

    The novel gene therapy KB707 is a replication-defective herpes simplex virus type 1–based vector encoding human interleukin (IL)-12 and IL-2. The agent is intended to bring high cytokine doses to the local tumor microenvironment.

    In the open-label, dose-escalation and -expansion KYANITE-1 study, investigators enrolled patients with at least 1 measurable lung lesion and a histologically confirmed solid tumor malignancy of the lungs to participate in the KB707 monotherapy portion of the study.

    The trial is also enrolling patients with histologically or cytologically confirmed stage III/IV NSCLC to receive KB707 in combination with pembrolizumab (Keytruda) with or without chemotherapy. Notably, eligible patients from the monotherapy cohorts are allowed to roll over to participate in the combination cohorts.

    During the monotherapy phase, KB707 was administered at doses ranging from 108 to 109 plaque-forming units (PFU; n = 16). During dose expansion (n = 23), patients received the agent at 109 PFU. The agent was administered on days 1, 8, 15, 36+, and 57+, with tumor evaluation also performed on day 57 or beyond.

    Safety, immunologic biomarkers, and preliminary efficacy were the primary objectives for the monotherapy portion of the study.

    In the efficacy-evaluable cohort, the median age was 71 years (range, 54-77), and most patients were female (63.6%), had an ECOG performance status of 1 (90.9%), and had stage IV disease (100%). Additionally, 18.2% of patients had a PD-L1 expression of at least 1%, and 45.5% of patients had PD-L1 expression under 1%; PD-L1 status was unknown in 36.4% of patients.

    Patients had received a median of 4 prior lines of therapy. Notably, 63.6% of patients had undergone 1 prior line of immunotherapy, and 36.4% of patients had received at least 2 prior lines of immunotherapy.

    References

    1. Krystal Biotech announces update on development plans for oncology program KB707 and prioritization of inhaled KB707 for the treatment of non-small cell lung cancer. News release. Krystal Biotech. August 21, 2025. Accessed August 22, 2025. https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-update-development-plans-oncology
    2. Ma WW, McKean M, Villaruz L, et al. Inhaled KB707, a novel HSV-based immunotherapy, as a monotherapy in patients with advanced solid tumor malignancies affecting the lungs: Efficacy and safety results from a phase 1/2 study. J Clin Oncol. 2025;43(suppl 16):2575. doi:10.1200/JCO.2025.43.16_suppl.2575

    Continue Reading

  • Asteroid Bennu’s Complex Origins Unveiled by Researchers

    Asteroid Bennu’s Complex Origins Unveiled by Researchers

    New analyses of the samples taken from asteroid Bennu by NASA’s OSIRIS-REx have revealed new insights into its origin – and The University of Manchester’s scientists have played a key role.

    A series of three new papers published this week in Nature Astronomy and Nature Geoscience, reveal that Bennu is a mix of dust formed in our solar system, organic matter from interstellar space and stardust that predates the solar system itself. The asteroid is thought to have formed from fragments of a larger parent asteroid destroyed by a collision in the asteroid belt between the orbits of Mars and Jupiter.

    In the first paper, co-led by researchers at the University of Arizona and NASA’s Johnson Space Center, published in the journal Nature Astronomy, Manchester researchers studied the gases trapped inside Bennu’s samples – in particular xenon, which is a very rare gas. Their measurements showed that Bennu’s gases resembled those found in some of the most primitive meteorites found on earth and materials returned from asteroid Ryugu by Japan’s Hayabusa2 mission.

    When combined with other elemental and isotopic analyses, the results suggest that Bennu’s parent body contained material from a range of origins, close to the Sun, far from the Sun, and even some grains from beyond our solar system.

    The findings also show that while much of the materials in the parent asteroid had been affected by water and heat, some of the material had escaped various chemical processes and retained its original chemical signatures. Some even survived the extremely energetic collision that broke it apart and formed Bennu.

    The studies also show that while some of Bennu’s original material survived unchanged, similarly, much of it was transformed by reactions with water. Minerals in its parent asteroid likely formed, dissolved, and re-formed over time, with up to 80% of Bennu’s material now made up of water-bearing minerals.

    These findings were reported in a second paper the paper published in Nature Geoscience co-led by the University of Arizona and the Smithsonian’s National Museum of Natural History, and included contributions from Professor Rhian Jones at The University of Manchester.

    In the third paper, co-led by Lindsay Keller at NASA’s Johnson Space Center and Michelle Thompson of Purdue University, also published in Nature Geoscience, researchers found microscopic craters and tiny splashes of once-molten rock – known as impact melts – on the sample surfaces – signs that the asteroid was bombarded by micrometeorites. These impacts, together with the effects of solar wind, are known as space weathering and occurred because Bennu has no atmosphere to protect it.

    Lindsay Keller at NASA’s Johnson Space Center, said: “The surface weathering at Bennu is happening a lot faster than conventional wisdom would have it, and the impact melt mechanism appears to dominate, contrary to what we originally thought.

    “Space weathering is an important process that affects all asteroids, and with returned samples, we can tease out the properties controlling it and use that data and extrapolate it to explain the surface and evolution of asteroid bodies that we haven’t visited.”

    As leftovers from the formation of planets 4.5 billion years ago, asteroids like Bennu provide a valuable record of solar system history. Unlike meteorites that fall to Earth, which often burn up or are altered in the atmosphere, Bennu’s pristine samples give scientists a rare opportunity to study untouched material.

    The project brings together researchers from NASA, universities and research centres around the world – including the UK, the United States, Japan and Canada – to study Bennu’s samples and unlock new insights into the origins of the solar system.

    /Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.

    Continue Reading

  • Oil prices set for weekly gain as Ukraine peace process stalls – Reuters

    1. Oil prices set for weekly gain as Ukraine peace process stalls  Reuters
    2. Oil prices fall on talks to end Russian invasion of Ukraine  Dawn
    3. WTI extends the rally to near $63.50 amid signs of stronger energy demand  FXStreet
    4. Oil prices gain as US inventory withdrawals point to strong demand  Profit by Pakistan Today
    5. Inventory Drop Boosts WTI, Rate Cut Uncertainty Holds Markets  FOREX.com

    Continue Reading

  • Amazon lobbies Indian government to exempt exports from foreign investment rules, sources say By Reuters – Investing.com

    1. Amazon lobbies Indian government to exempt exports from foreign investment rules, sources say By Reuters  Investing.com
    2. Exporters selling via Amazon e-commerce exports on the rise  The Hindu
    3. Amazon wants to export from India, promises no competition in domestic market  Cryptopolitan
    4. Amazon (AMZN) Asks Indian Government to Loosen Its Foreign Investment Rules  TipRanks
    5. Amazon lobbies Indian government to exempt exports from foreign investment rules, sources say  Yahoo Finance

    Continue Reading

  • Researchers find red meat might increase abdominal aneurysm risk

    Researchers find red meat might increase abdominal aneurysm risk

    A new study by Cleveland Clinic researchers suggests eating red meat could increase a person’s risk of a potentially deadly abdominal aortic aneurysm. File Photo by Shou Sheng/EPA

    Chowing down on red meat might increase a person’s risk of a potentially deadly blood vessel problem of the abdomen, a new study says.

    High blood levels of TMAO (trimethylamine N-oxide) — a byproduct of gut bacteria digestion of red meat and other animal-based foods — are linked to an increased risk of abdominal aortic aneurysm, or AAA, researchers report in JAMA Cardiology.

    AAA occurs when a bulge develops in the aorta, the large artery that runs through the torso, researchers said in background notes.

    If this bulge ruptures, it is deadly in as many as 80% of cases that occur outside a hospital, researchers said.

    “These results suggest targeting TMAO levels may help prevent and treat aneurysmal disease beyond surgery,” lead researcher Dr. Scott Cameron, section head of vascular medicine at the Cleveland Clinic, said in a news release.

    Millions of patients develop AAA every year, researchers said.

    Normally, the aorta’s wall is strong enough to handle the constant pressure of blood pumped from the heart. When a part of the aorta weakens, a dangerous bulge forms there, and as it grows larger so does the risk of it rupturing.

    Currently, surgery or stenting are the only treatment options for AAA, Cameron said, and no blood tests are available to predict who’s at risk for an aneurysm.

    AAA patients usually have no symptoms until the aorta ruptures, causing massive bleeding inside their torso, researchers said.

    For the new study, researchers analyzed data from 237 Europeans and 658 Americans, including both healthy people and folks diagnosed with AAA.

    Results showed that high blood levels of TMAO were linked to a more than tripled risk of AAA.

    Elevated TMAO levels also were associated with a more than doubled risk of a fast-growing aneurysm that could be potentially dangerous, researchers said.

    These results could lead to an effective blood test for AAA, researchers said.

    They also could help people at risk for AAA take steps to protect themselves by cutting down on red meat, researchers said. Aging, smoking and other medical conditions are known to increase risk for the disorder.

    “TMAO is made by gut microbes, with levels being higher when eating animal products and red meat,” senior researcher Dr. Stanley Hazen, chair of cardiovascular and metabolic sciences at the Cleveland Clinic, said in a news release.

    “Medication targeting this pathway has been shown to block aneurysm development and rupture in preclinical models but are not yet available for humans,” he said. “These results are important to share because they show how important diet may be in helping prevent or treat patients with aorta dilation or early aneurysm compared to current clinical practice, which is to monitor until surgery is needed.”

    However, further study is needed to directly link a diet heavy in red meat and animal products with AAA, researchers noted.

    More information

    Johns Hopkins Medicine has more about abdominal aortic aneurysm.

    Copyright © 2025 HealthDay. All rights reserved.

    Continue Reading